A study using the drosophila model of HD showed that D-penicillamine, a Cu chelator, significantly reduced the formation of amyloid-like huntingtin aggregates, suggesting a potential therapeutic avenue for mitigating the toxicity associated with huntingtin aggregation [15]. This evidence concerns the gene HTT and Huntington disease.